Cargando…

The ER Aminopeptidases, ERAP1 and ERAP2, synergize to self-modulate their respective activities

INTRODUCTION: Critical steps in Major Histocompatibility Complex Class I (MHC-I) antigen presentation occur in the endoplasmic reticulum (ER). In general, peptides that enter the ER are longer than the optimal length for MHC-I binding. The final trimming of MHC-I epitopes is performed by two related...

Descripción completa

Detalles Bibliográficos
Autores principales: Martín-Esteban, Adrian, Rodriguez, Jesus Contreras, Peske, David, Lopez de Castro, Jose A., Shastri, Nilabh, Sadegh-Nasseri, Scheherazade
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9774488/
https://www.ncbi.nlm.nih.gov/pubmed/36569828
http://dx.doi.org/10.3389/fimmu.2022.1066483
_version_ 1784855420424159232
author Martín-Esteban, Adrian
Rodriguez, Jesus Contreras
Peske, David
Lopez de Castro, Jose A.
Shastri, Nilabh
Sadegh-Nasseri, Scheherazade
author_facet Martín-Esteban, Adrian
Rodriguez, Jesus Contreras
Peske, David
Lopez de Castro, Jose A.
Shastri, Nilabh
Sadegh-Nasseri, Scheherazade
author_sort Martín-Esteban, Adrian
collection PubMed
description INTRODUCTION: Critical steps in Major Histocompatibility Complex Class I (MHC-I) antigen presentation occur in the endoplasmic reticulum (ER). In general, peptides that enter the ER are longer than the optimal length for MHC-I binding. The final trimming of MHC-I epitopes is performed by two related aminopeptidases, ERAP1 and ERAP2 in humans that possess unique and complementary substrate trimming specificities. While ERAP1 efficiently trims peptides longer than 9 residues, ERAP2 preferentially trims peptides shorter than 9 residues. MATERIALS AND METHODS: Using a combination of biochemical and proteomic studies followed by biological verification. RESULTS: We demonstrate that the optimal ligands for either enzyme act as inhibitors of the other enzyme. Specifically, the presence of octamers reduced the trimming of long peptides by ERAP1, while peptides longer than nonomers inhibit ERAP2 activity. DISCUSSION: We propose a mechanism for how ERAP1 and ERAP2 synergize to modulate their respective activities and shape the MHC-I peptidome by generating optimal peptides for presentation.
format Online
Article
Text
id pubmed-9774488
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97744882022-12-23 The ER Aminopeptidases, ERAP1 and ERAP2, synergize to self-modulate their respective activities Martín-Esteban, Adrian Rodriguez, Jesus Contreras Peske, David Lopez de Castro, Jose A. Shastri, Nilabh Sadegh-Nasseri, Scheherazade Front Immunol Immunology INTRODUCTION: Critical steps in Major Histocompatibility Complex Class I (MHC-I) antigen presentation occur in the endoplasmic reticulum (ER). In general, peptides that enter the ER are longer than the optimal length for MHC-I binding. The final trimming of MHC-I epitopes is performed by two related aminopeptidases, ERAP1 and ERAP2 in humans that possess unique and complementary substrate trimming specificities. While ERAP1 efficiently trims peptides longer than 9 residues, ERAP2 preferentially trims peptides shorter than 9 residues. MATERIALS AND METHODS: Using a combination of biochemical and proteomic studies followed by biological verification. RESULTS: We demonstrate that the optimal ligands for either enzyme act as inhibitors of the other enzyme. Specifically, the presence of octamers reduced the trimming of long peptides by ERAP1, while peptides longer than nonomers inhibit ERAP2 activity. DISCUSSION: We propose a mechanism for how ERAP1 and ERAP2 synergize to modulate their respective activities and shape the MHC-I peptidome by generating optimal peptides for presentation. Frontiers Media S.A. 2022-12-08 /pmc/articles/PMC9774488/ /pubmed/36569828 http://dx.doi.org/10.3389/fimmu.2022.1066483 Text en Copyright © 2022 Martín-Esteban, Rodriguez, Peske, Lopez de Castro, Shastri and Sadegh-Nasseri https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Martín-Esteban, Adrian
Rodriguez, Jesus Contreras
Peske, David
Lopez de Castro, Jose A.
Shastri, Nilabh
Sadegh-Nasseri, Scheherazade
The ER Aminopeptidases, ERAP1 and ERAP2, synergize to self-modulate their respective activities
title The ER Aminopeptidases, ERAP1 and ERAP2, synergize to self-modulate their respective activities
title_full The ER Aminopeptidases, ERAP1 and ERAP2, synergize to self-modulate their respective activities
title_fullStr The ER Aminopeptidases, ERAP1 and ERAP2, synergize to self-modulate their respective activities
title_full_unstemmed The ER Aminopeptidases, ERAP1 and ERAP2, synergize to self-modulate their respective activities
title_short The ER Aminopeptidases, ERAP1 and ERAP2, synergize to self-modulate their respective activities
title_sort er aminopeptidases, erap1 and erap2, synergize to self-modulate their respective activities
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9774488/
https://www.ncbi.nlm.nih.gov/pubmed/36569828
http://dx.doi.org/10.3389/fimmu.2022.1066483
work_keys_str_mv AT martinestebanadrian theeraminopeptidaseserap1anderap2synergizetoselfmodulatetheirrespectiveactivities
AT rodriguezjesuscontreras theeraminopeptidaseserap1anderap2synergizetoselfmodulatetheirrespectiveactivities
AT peskedavid theeraminopeptidaseserap1anderap2synergizetoselfmodulatetheirrespectiveactivities
AT lopezdecastrojosea theeraminopeptidaseserap1anderap2synergizetoselfmodulatetheirrespectiveactivities
AT shastrinilabh theeraminopeptidaseserap1anderap2synergizetoselfmodulatetheirrespectiveactivities
AT sadeghnasserischeherazade theeraminopeptidaseserap1anderap2synergizetoselfmodulatetheirrespectiveactivities
AT martinestebanadrian eraminopeptidaseserap1anderap2synergizetoselfmodulatetheirrespectiveactivities
AT rodriguezjesuscontreras eraminopeptidaseserap1anderap2synergizetoselfmodulatetheirrespectiveactivities
AT peskedavid eraminopeptidaseserap1anderap2synergizetoselfmodulatetheirrespectiveactivities
AT lopezdecastrojosea eraminopeptidaseserap1anderap2synergizetoselfmodulatetheirrespectiveactivities
AT shastrinilabh eraminopeptidaseserap1anderap2synergizetoselfmodulatetheirrespectiveactivities
AT sadeghnasserischeherazade eraminopeptidaseserap1anderap2synergizetoselfmodulatetheirrespectiveactivities